March 3, 2016 QoC Health is a technology partner on McMaster University’s SMArTVIEW project. The $12.3 million project has recently received a $750,000 grant from the eHealth Innovation Partnership Program (eHIPP) from Canadian Institutes of Health Research (CIHR).
Globe & Mail Report On Business Publishes Op-Ed Penned By NACO's Co-Chairs, Ian Bandeen And Bev Tudhop
Self Care Cataysts - Featured Article, Inc. Magazine
Grace Soyao, Founder & CEO, Self Care Catalysts Inc. writes about "Creating Breakthroughs in Entreprneurship" in 4 key steps.
Click here for the full article
Interface Biologics Announces the Extension of its Licensing Agreement with Fresenius Medical Care
TORONTO, Canada, February 9, 2016 - Interface Biologics Inc. (IBI) is pleased to announce that Fresenius Medical Care, the worlds’ largest integrated provider of dialysis products and services, has extended their exclusive licensing agreement for use of Endexo™ technology in chronic dialysis systems to cover the acute dialysis market (including CRRT).
Focal Healthcare receives 510(k) clearance from the FDA for their targeted prostate biopsy device, Fusion Bx
PlantForm Corporation awarded Government of Canada contract for plant-based production of anti-ricin antibody
Sernova Honoured as Member of the “2016 TSX Venture 50” and Ranked #4 in Life Sciences and Clean Technologies
TO Health! announces its evolution and Summit to make Toronto region cluster Top 5 in 10
Rna Diagnostics announces new study in chemotherapy efficacy in canine lymphoma
Rna Diagnostics Inc announced today a new study to investigate RDA as a predictor for chemotherapy efficacy in canine lymphoma in partnership with University of Guelph Institute for Comparative Cancer Investigation and the Mona Campbell Centre for Animal Cancer at the Ontario Veterinary College. This study of canine lymphoma is based on the success of an initial canine lymphoma study completed in 2014.
NOVADAQ Announces Fourth Quarter 2015 Preliminary Unaudited Revenues and Issues 2016 Revenue Guidance
TORONTO, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Novadaq Technologies Inc. (“NOVADAQ” or the “Company”) (NVDQ) (NDQ.TO), the leading developer and provider of clinically relevant fluorescence imaging solutions for use in surgical and diagnostic procedures, announced today preliminary unaudited revenue for the fourth quarter of 2015 and provided 2016 revenue guidance ahead of its participation at the 34th Annual J.P. Morgan Healthcare Conference in San Francisco, CA.
Moseda Announces Appointment of Experienced Healthcare Technology Executive
VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 18, 2016) - Moseda Technologies Inc. (TSX VENTURE:MSD) ("Moseda" or the "Company"), a technology company focused on developing progressive mobile health (mHealth) and telemedicine solutions for institutional and home healthcare, is pleased to announce that it has appointed industry expert Dr. Lisa Crossley, PhD., P.Eng. as CEO and Director and Mr. Sameet Kanade as President and Chairman of the Board as the Company aims to ramp up its client acquisition strategy.
Proteocyte Receives Support from NRC-IRAP for Straticyte™ Intellectual Property Development
Vive Crop Protection Receives EPA Registration for Bifender At-Plant Insecticide
The United States Environmental Protection Agency has approved Vive Crop Protection's Bifender™ insecticide using Vive's proprietary Allosperse® delivery technology. The product contains bifenthrin, an excellent broad-spectrum insecticide, and is targeted for early-season in-furrow or soil applications.
Sernova Corp to Present at the Biotech Showcase(TM) 2016 in San Francisco on January 13, 2016
Sernova Corp. (TSX-V: SVA) (OTCQB: SEOVF) (FSE: PSH), a clinical stage regenerative medicine company, today announced that Dr. Philip Toleikis, Sernova’s President and CEO, will be providing a corporate update at the 8th annual Biotech Showcase Conference in San Francisco, CA, at 4:00 p.m. PST on January 13, 2016 in San Francisco, California.
In a full roster of business development meetings, Dr. Toleikis will also be updating key pharma and institutional audiences on the company's progress and future plans.
Proteocyte Receives Support from NRC-IRAP for Straticyte™
SERNOVA AWARDED EUROPE’S PRESTIGIOUS HORIZON 2020 GRANT
Canada shows a “disturbing” decline in innovation and R&D
Dose of the Valley - Call for Applications
Launch of the second Canada-Chicago Mentoring Program (C2MP)
The Consulate General of Canada in Chicago successfully partnered in 2015 (testimonials included in our enclosed marketing document for the 2016 program) with the Chicago Innovation Mentors (CIM) to provide a comprehensive mentoring program for three Canadian life science and healthcare entrepreneurs.
It is our pleasure to announce that the program has been renewed for 2016. The Consulate will again be able to funnel three Canadian start-ups through CIM’s mentoring program.
Spectral to Present at the 20th International Conference on Advances in Critical Care Nephrology (AKI & CRRT) in San Diego
Spectral Medical Inc., a Phase III company developing the first therapy for patients with septic shock guided by a diagnostic, today announced that it will present at the upcoming 20th International Conference on Advances in Critical Care Nephrology (AKI & CRRT) conference in San Diego, California on February 18, 2015 during an interactive luncheon session.